| Heme oxygenase-1 in tumors: is it a false friend? A Jozkowicz, H Was, J Dulak Antioxidants & redox signaling 9 (12), 2099-2118, 2007 | 470 | 2007 |
| Stromal cell–derived factor 1 promotes angiogenesis via a heme oxygenase 1–dependent mechanism J Deshane, S Chen, S Caballero, A Grochot-Przeczek, H Was, S Li Calzi, ... The Journal of experimental medicine 204 (3), 605-618, 2007 | 344 | 2007 |
| Heme oxygenase-1 in tumor biology and therapy H Was, J Dulak, A Jozkowicz Current drug targets 11 (12), 1551-1570, 2010 | 306 | 2010 |
| Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice H Was, T Cichon, R Smolarczyk, D Rudnicka, M Stopa, C Chevalier, ... The American journal of pathology 169 (6), 2181-2198, 2006 | 241 | 2006 |
| Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice H Was, T Cichon, R Smolarczyk, D Rudnicka, M Stopa, C Chevalier, ... The American journal of pathology 169 (6), 2181-2198, 2006 | 241 | 2006 |
| Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis K Skrzypek, M Tertil, S Golda, M Ciesla, K Weglarczyk, G Collet, ... Antioxidants & redox signaling 19 (7), 644-660, 2013 | 175 | 2013 |
| Polyploidy formation in doxorubicin-treated cancer cells can favor escape from senescence G Mosieniak, MA Sliwinska, O Alster, A Strzeszewska, P Sunderland, ... Neoplasia 17 (12), 882-893, 2015 | 149 | 2015 |
| Heme oxygenase-1 accelerates cutaneous wound healing in mice A Grochot-Przeczek, R Lach, J Mis, K Skrzypek, M Gozdecka, ... Plos one 4 (6), e5803, 2009 | 145 | 2009 |
| Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs M Kozakowska, M Ciesla, A Stefanska, K Skrzypek, H Was, A Jazwa, ... Antioxidants & redox signaling 16 (2), 113-127, 2012 | 134 | 2012 |
| Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants H Taha, K Skrzypek, I Guevara, A Nigisch, S Mustafa, A Grochot-Przeczek, ... Arteriosclerosis, thrombosis, and vascular biology 30 (8), 1634-1641, 2010 | 128 | 2010 |
| Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice D Nowis, M Bugajski, M Winiarska, J Bil, A Szokalska, P Salwa, T Issat, ... BMC cancer 8, 1-12, 2008 | 83 | 2008 |
| Mechanisms of chemotherapy-induced neurotoxicity H Was, A Borkowska, A Bagues, L Tu, JYH Liu, Z Lu, JA Rudd, K Nurgali, ... Frontiers in pharmacology 13, 750507, 2022 | 82 | 2022 |
| Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features H Was, J Czarnecka, A Kominek, K Barszcz, T Bernas, K Piwocka, ... Cancer biology & therapy 19 (1), 63-75, 2018 | 75 | 2018 |
| Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice H Was, M Sokolowska, A Sierpniowska, P Dominik, K Skrzypek, ... Free Radical Biology and Medicine 51 (9), 1717-1726, 2011 | 66 | 2011 |
| Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells H Was, SK Krol, D Rotili, A Mai, B Wojtas, B Kaminska, M Maleszewska Clinical Epigenetics 11, 1-13, 2019 | 64 | 2019 |
| Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice H Was, K Barszcz, J Czarnecka, A Kowalczyk, T Bernas, E Uzarowska, ... Oncotarget 8 (6), 9303, 2017 | 56 | 2017 |
| Polyploidy formation in cancer cells: How a Trojan horse is born H Was, A Borkowska, A Olszewska, A Klemba, M Marciniak, A Synowiec, ... Seminars in cancer biology 81, 24-36, 2022 | 50 | 2022 |
| Hypoxia-mediated decrease of ovarian cancer cells reaction to treatment: significance for chemo-and immunotherapies A Klemba, L Bodnar, H Was, KK Brodaczewska, G Wcislo, CA Szczylik, ... International journal of molecular sciences 21 (24), 9492, 2020 | 37 | 2020 |
| Janus face of Nrf2–HO-1 axis in cancer—Friend in chemoprevention, foe in anticancer therapy A Loboda, H Was, A Jozkowicz, J Dulak Lung Cancer 60 (1), 1-3, 2008 | 34 | 2008 |
| Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1 M Tertil, K Skrzypek, U Florczyk, K Weglarczyk, H Was, G Collet, ... PLoS One 9 (5), e97070, 2014 | 31 | 2014 |
